Publications by authors named "Heinz Gisslinger"

100Publications

Austrian recommendations for the management of essential thrombocythemia.

Wien Klin Wochenschr 2020 Nov 19. Epub 2020 Nov 19.

Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
November 2020

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.

Eur J Haematol 2021 Jan 6;106(1):58-63. Epub 2020 Oct 6.

Department of Haematology and Blood Coagulation, Division of Internal Medicine I,, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
January 2021

Acute oxygenator occlusion in two cases of polycythemia vera: Bailout strategies.

J Card Surg 2020 Oct 15;35(10):2835-2837. Epub 2020 Jul 15.

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2020

GDF-15 in solid vs non-solid treatment-naïve malignancies.

Eur J Clin Invest 2019 Nov 26;49(11):e13168. Epub 2019 Sep 26.

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
November 2019

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Wien Klin Wochenschr 2018 Sep 24;130(17-18):495-504. Epub 2018 Jul 24.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2018

Austrian recommendations for the management of polycythemia vera.

Wien Klin Wochenschr 2018 Sep 19;130(17-18):535-542. Epub 2018 Jul 19.

Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2018

Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet count.

Transl Res 2018 10 13;200:35-42. Epub 2018 Jun 13.

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2018

Pre-PMF emerging as important subgroup of MPN.

Authors:
Heinz Gisslinger

Blood 2017 06;129(24):3142-3144

MEDICAL UNIVERSITY OF VIENNA.

View Article and Find Full Text PDF
June 2017

Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?

Haematologica 2016 12;101(12):e492

Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Austria.

View Article and Find Full Text PDF
December 2016

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.

J Clin Oncol 2016 10;34(30):3609-3617

Cyrille Hulin, Bordeaux Hospital University Center, Bourdeaux; Philippe Rodon, Centre Hospitalier de Périgueux, Périgueux; Brigitte Pégourié, Centre Hospitalier Regional Universitaire, Grenoble; Laurent Garderet, Centre Hospitalier Universitaire (CHU) Hôpital St-Antoine, Paris; Isabelle Azais, CHU Institut National de la Santé et de la Recherche Médicale (INSERM); Xavier Leleu, Hôpital de la Milétrie, CHU INSERM, Poitiers; Margaret Macro, CHU de Caen, Caen; Bruno Royer, University Hospital, Amiens; Thierry Facon, Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France; Andrew Belch, Cross Cancer Institute, Edmonton, Alberta; Chaim Shustik, Royal Victoria Hospital; Richard LeBlanc, Hôpital Maisonneuve-Rosemont, Montreal, Quebec; Kevin Song, Vancouver General Hospital, Vancouver, British Columbia, Canada; Maria Teresa Petrucci, Azienda Policlinico Umberto I, University La Sapienza, Rome, Italy; Ulrich Dührsen, University Hospital of Essen, West German Cancer Center, Essen, Germany; Jin Lu, Peking University Institute of Hematology, People's Hospital, Beijing, China; Hannah Hunter, Derriford Hospital, Plymouth, United Kingdom; Richard Eek, Border Medical Oncology, Wodonga, Victoria, Australia; Heinz Gisslinger, Medizinische Universität Wien, Vienna, Austria; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Cristina Goncalves, Hospital de Santo Antonio-Porto, Porto, Portugal; Ken Romeril, Wellington Hospital, Wellington, New Zealand; Chantal Doyen, Université Catholique de Louvain (UCL), CHU UCL Namur, Yvoir; Fritz Offner, Universitair Ziekenhuis Gent, Ghent, Belgium; Nicolas Leupin, Celgene International, Boudry, Switzerland; Vanessa Houck, Guang Chen, and Annette Ervin-Haynes, Celgene, Summit, NJ; and Meletios A. Dimopoulos, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.

View Article and Find Full Text PDF
October 2016

In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.

Eur J Haematol 2016 Dec 15;97(6):562-567. Epub 2016 Jun 15.

Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
December 2016

[In Process Citation].

Leuk Res 2016 05 26;44 Suppl 1. Epub 2016 Apr 26.

Deputy Chair of CEMPO (Central European Myeloproliferative Neoplasm Organization).

View Article and Find Full Text PDF
May 2016

Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.

Eur J Haematol 2016 Dec 23;97(6):511-516. Epub 2016 May 23.

Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
December 2016

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans.

Genome Biol 2016 Jan 29;17:14. Epub 2016 Jan 29.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, 1090, Vienna, Austria.

View Article and Find Full Text PDF
January 2016

Germline RBBP6 mutations in familial myeloproliferative neoplasms.

Blood 2016 Jan 16;127(3):362-5. Epub 2015 Nov 16.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;

View Article and Find Full Text PDF
January 2016

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Blood 2016 Jan 30;127(3):325-32. Epub 2015 Sep 30.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;

View Article and Find Full Text PDF
January 2016

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Blood 2015 Oct 10;126(15):1762-9. Epub 2015 Aug 10.

Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.

View Article and Find Full Text PDF
October 2015

Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.

Haematologica 2015 Jun 3;100(6):757-67. Epub 2015 Apr 3.

INSERM UMR-S1197, Paul Brousse Hospital, Paris-Sud University, Villejuif, France INSERM UMS33, Paul Brousse Hospital, Paris-Sud University, Villejuif, France French Intergroup on Myeloproliferative Neoplasms (FIM), France

View Article and Find Full Text PDF
June 2015

Current and future treatment options for polycythemia vera.

Ann Hematol 2015 Jun 2;94(6):901-10. Epub 2015 Apr 2.

Johannes Wesling Academic Medical Center, Minden, Germany,

View Article and Find Full Text PDF
June 2015

Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosis.

Eur J Haematol 2015 Sep 7;95(3):239-43. Epub 2015 Jan 7.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2015

Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.

Am J Hematol 2014 Dec 27;89(12):1157-8. Epub 2014 Aug 27.

5th Department of Internal Medicine - Oncology/Hematology, Hospital Hietzing, Vienna, Austria; Ludwig Boltzmann Institute for Clinical Oncology, Vienna, Austria.

View Article and Find Full Text PDF
December 2014

Somatic mutations of calreticulin in myeloproliferative neoplasms.

N Engl J Med 2013 Dec 10;369(25):2379-90. Epub 2013 Dec 10.

From CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (T.K., A.S.H., H.N., J.D.M., N.C.C.T., T.B., D.C., G.I.V., K.B., F.S., C.C., M. Six, A.S., C.B., G.S.-F., R.K.) and the Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna (H.G., B.G., M. Schalling, R.K.) - both in Vienna; and the Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo (E.R., D.P., C.M., I.C.C., E.S., V.F., C.E., L.M., C.P., M.C.), and the Department of Molecular Medicine, University of Pavia (L.M., M.C.) - both in Pavia, Italy.

View Article and Find Full Text PDF
December 2013

High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosis.

Leuk Res 2014 Jan 14;38(1):116-20. Epub 2013 Oct 14.

5th Department of Internal Medicine - Oncology/Hematology, Hospital Hietzing, Vienna, Austria; Ludwig Boltzmann Institute for Clinical Oncology, Vienna, Austria. Electronic address:

View Article and Find Full Text PDF
January 2014

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

Blood 2013 Mar 11;121(10):1720-8. Epub 2013 Jan 11.

Medical University of Vienna, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Vienna, Austria.

View Article and Find Full Text PDF
March 2013